Autologous EBV-specific Cytotoxic T Cells in Systemic Lupus Erythematosus: An Innovative Phase I/IIa Clinical Trial

被引：0
|
作者：
Enfrein, Antoine [1 ]
Clemenceau, Beatrice [2 ]
Saiagh, Soraya [3 ]
Bressollette, Celine [4 ]
Amoura, Zahir [5 ]
Vie, Henri [2 ]
Hamidou, Mohamed [1 ]
机构：
[1] CHU Nantes, Med Interne, Nantes, France
[2] Univ Nantes, Inserm U1232, Nantes, France
[3] CHU Nantes, Unite Therapie Cellulaire & Genique, Nantes, France
[4] CHU Nantes, Lab Virol, Nantes, France
[5] Hop La Pitie Salpetriere, AP HP, Med Interne, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页码：3691 / 3691
页数：1
相关论文
共 50 条
  • [31] A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS
    Penas-Prado, Marta
    Weathers, Shiao-Pei
    Zhou, Shouhao
    Kamiya-Matsuoka, Carlos
    O'Brien, Barbara
    Loghin, Monica
    Harrison, Rebecca
    Pei, Be Lian
    Ictech, Sandra
    Hunter, Kathy
    Yung, W. K. Alfred
    de Groot, John
    Shpall, Elizabeth J.
    Heimberger, Amy
    Rezvani, Katy
    NEURO-ONCOLOGY, 2018, 20 : 2 - 3
  • [32] A phase I/II clinical trial of autologous CMV-specific cytotoxic T cells (CMV-TC) for glioblastoma: Dose escalation results.
    Penas-Prado, Marta
    Rezvani, Katayoun
    Weathers, Shiao-Pei S.
    Zhou, Shouhao
    Kamiya-Matsuoka, Carlos
    O'Brien, Barbara Jane
    Loghin, Monica Elena
    Harrison, Rebecca Anne
    Pei, Be Lian
    Ictech, Sandra
    Hunter, Kathy
    Yung, W. K. Alfred
    De Groot, John Frederick
    Shpall, Elizabeth J.
    Heimberger, Amy B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Autologous Anti-CD19 CAR T Cells as Therapy for Systemic Lupus Erythematosus
    Radic, Marko
    Randolph, Brion
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (01): : 3 - 4
  • [34] Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
    Nguyen Thanh Liem
    Nguyen Van Phong
    Nguyen Trung Kien
    Bui Viet Anh
    Truong Linh Huyen
    Chu Thi Thao
    Nguyen Dac Tu
    Doan Trung Hiep
    Do Thi Hoai Thu
    Hoang Thi My Nhung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [35] Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
    Roemhild, Andy
    Otto, Natalie Maureen
    Moll, Guido
    Abou-El-Enein, Mohamed
    Kaiser, Daniel
    Bold, Gantuja
    Schachtner, Thomas
    Choi, Mira
    Oellinger, Robert
    Landwehr-Kenzel, Sybille
    Juerchott, Karsten
    Sawitzki, Birgit
    Giesler, Cordula
    Sefrin, Anett
    Beier, Carola
    Wagner, Dimitrios Laurin
    Schlickeiser, Stephan
    Streitz, Mathias
    Schmueck-Henneresse, Michael
    Amini, Leila
    Stervbo, Ulrik
    Babel, Nina
    Volk, Hans-Dieter
    Reinke, Petra
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [36] BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
    Wang, Weijia
    He, Shanzhi
    Zhang, Wenli
    Zhang, Hongyu
    DeStefano, Vincent M.
    Wada, Masayuki
    Pinz, Kevin
    Deener, Greg
    Shah, Darshi
    Hagag, Nabil
    Wang, Min
    Hong, Ming
    Zeng, Ronghao
    Lan, Ting
    Ma, Yu
    Li, Fugui
    Liang, Yingwen
    Guo, Zhencong
    Zou, Chanjuan
    Wang, Mingxia
    Ding, Ling
    Ma, Yupo
    Yuan, Yong
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (10) : 1304 - 1314
  • [37] Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
    Louis, Chrystal U.
    Straathof, Karin
    Bollard, Catherine M.
    Ennamuri, Sravya
    Gerken, Claudia
    Lopez, Teresita T.
    Huls, M. Helen
    Sheehan, Andrea
    Wu, Meng-Fen
    Liu, Hao
    Gee, Adrian
    Brenner, Malcolm K.
    Rooney, Cliona M.
    Heslop, Helen E.
    Gottschalk, Stephen
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (09) : 983 - 990
  • [38] IMMUNE ESCAPE BY EPSTEIN-BARR-VIRUS (EBV) CARRYING BURKITTS-LYMPHOMA - INVITRO RECONSTITUTION OF SENSITIVITY TO EBV-SPECIFIC CYTOTOXIC T-CELLS
    MASUCCI, MG
    ZHANG, QJ
    GAVIOLI, R
    DECAMPOSLIMA, PO
    MURRAY, RJ
    BROOKS, J
    GRIFFIN, H
    PLOEGH, H
    RICKINSON, AB
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (11) : 1283 - 1292
  • [39] CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells
    Khanolkar, A
    Fu, Z
    Underwood, LJ
    Bondurant, KL
    Rochford, R
    Cannon, MJ
    JOURNAL OF IMMUNOLOGY, 2003, 170 (06): : 3187 - 3194
  • [40] Clinical protocol - A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants
    Lucas, KG
    Sun, Q
    Burton, RL
    Tilden, A
    Vaughan, WP
    Carabasi, M
    Salzman, D
    Ship, A
    HUMAN GENE THERAPY, 2000, 11 (10) : 1453 - 1463
12345